Insights
Looking Ahead: 2020 Workers’ Compensation Predictions
The new decade has arrived and we are taking a look ahead at the regulatory and compliance trends we expect to hit the workers’ compensation market this year. Keep reading to find out our 2020 workers’ compensation predictions.
The Future of Pain Therapy in Workers’ Compensation
4 MIN READ
As we move into a new decade, we continue to look for solutions to address the opioid crisis and discover alternative ways to treat pain. From a drug-therapy perspective, current alternatives to opioids include NSAIDs, anticonvulsants and occasionally certain antidepressants. Non-drug therapies include physical therapy, home exercise programs and electrical therapy treatments.
What's the difference between a drug allergy and a side effect?
3 MIN READ
Drug allergies and side effects present differences that are often misunderstood. They are commonly discussed in overlapping terms that can understate the importance in how each should be managed (Eg. “I think I’m allergic to Aspirin, it upsets my stomach”).
Disaster Recovery and Work Comp
1 MIN READ
In just the past few years, natural disasters have generated startling headlines and produced enormous challenges for many, including for workers’ compensation systems.
My Way, Right Now
3 MIN READ
How quickly do you get frustrated with slow service? Whether you are waiting a little longer for your food to be served at a restaurant, or even waiting on that red light that took forever this morning on the way to work, our patience continues to lessen.
Chronicling the World of Workers’ Comp with Roberto Ceniceros
Last month, workers’ compensation lost one of its most talented reporters and influencers as Roberto Ceniceros announced his retirement.
Gabapentinoids in Workers’ Compensation
6 MIN READ
Nearly 20 percent of U.S. adults suffer from chronic pain. This is especially vital in the workers’ compensation world that is now asking, ‘are gabapentinoids the answer to that pain?’ Current increases in prescribing of gabapentinoids and the drugs’ less addictive qualities as compared to opioids may initially suggest so.